No Prescription |
 |
 | ||
|
Kolsin Generic Colchicine |
|
| ||
No Prescription » Prescription Drugs 9 » Kolsin Generic Colchicine Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.This medication is used to treat gout.Colchicine when used regularly can help prevent a gout attack (e.g. gouty arthritis). Though not a true pain reliever colchicine relieves the pain that occurs with a gout attack. It is believed to act by decreasing the amount of swelling in the affected joint.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used for other types of arthritis and certain liver conditions and to prevent the aches and pains of a certain inherited disease (familial Mediterranean fever).How to use Colchicine OralTake this medication by mouth exactly as directed by your doctor. When prescribed "as needed" to prevent a gout attack from becoming too painful take 1 or 2 tablets followed by 1 tablet every hour or 2 tablets every 2 hours until the pain is gone or you have stomach upset or diarrhea. Colchicine controls pain best when taken at the first sign of a gout attack. This "as needed" dosing should not be done more than every 3 days.To prevent or lessen the number of gout attacks per year your doctor may Online you to take colchicine on a regular basis. Dosage will be based on your medical condition the number of gout attacks you have per year and your response to therapy. If you are directed to take colchicine regularly take it at the same time each day to help you remember.Before you have any surgery (including dental surgery) your dose may need to be increased a few days in advance and remain increased until a few days after surgery.Inform your doctor if joint pain persists if it worsens 12 hours after the beginning of the attack or if it is not completely gone in 2 days.Colchicine Oral may also be used to treat:Arthritis of the Toes and Fingers due to Sarcoidosis A Chronic Multisystem Inflammatory Disorder Inflammation of the Joints due to Gout Treatment to Prevent Gout Familial Mediterranean Fever Buy Kolsin Generic Colchicine and other Prescription Drugs 9 products online at Medstore. 4975
About Kolsin Generic Colchicine: Product Type: Prescription Drugs 9 Kolsin ( Generic Colchicine ) Kolsin (Generic Colchicine) Generic Colchicine 0 5 mg 60 tabs Generic Colchicine Kolsin
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
